Offer - Urjas Oil for just ₹ 1 X
Halonext S Ointment 30 Gm is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Halonext S Ointment 30 Gm safe for pregnant women?
Halonext S may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Halonext S again without your doctor's advice.
Is the use of Halonext S Ointment 30 Gm safe during breastfeeding?
Breastfeeding women can take Halonext S as it bears very minor side effects for them.
What is the effect of Halonext S Ointment 30 Gm on the Kidneys?
Halonext S does not damage the kidneys.
What is the effect of Halonext S Ointment 30 Gm on the Liver?
Halonext S is not harmful for the liver.
What is the effect of Halonext S Ointment 30 Gm on the Heart?
There are no any side effects of Halonext S for the heart.
Halonext S Ointment 30 Gm should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Halonext S Ointment 30 Gm unless your doctor advises you to do so -
Is this Halonext S Ointment 30 Gm habit forming or addictive?
Halonext S Ointment 30 Gm does not cause addiction.
Interaction between Food and Halonext S Ointment 30 Gm
Taking Halonext S Ointment 30 Gm with food is safe.
Interaction between Alcohol and Halonext S Ointment 30 Gm
It is difficult to say anything about the effect of Halonext S Ointment 30 Gm and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 889
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Halobetasol Propionate
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 369-372